IDH2 and glioma: However, D2-HG is only a relatively weak inhibitor of HIF-PHD [64], and following studies found no correlation between IDH mutation status and the expression of HIF1α in patients with glioma [119,120] or in the brains of adult mice where mutant idh1 was expressed [71].